APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-based Medical Imaging Tool

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI-based Medical Imaging Tool Market Outlook and Growth Opportunities 2026

22 January 2026214 pages

Choose your research edition.

Industry ResearchAI-based Medical Imaging Tool Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Medical Imaging Tool Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI-based Medical Imaging Tool Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Medical Imaging Tool Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Medical Imaging Tool Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global AI-based Medical Imaging Tool market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-based Medical Imaging Tool is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-based Medical Imaging Tool is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-based Medical Imaging Tool is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-based Medical Imaging Tool market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-based Medical Imaging Tool market include ScreenPoint Medical, Volpara Solutions, CureMetrix, Densitas, Enlitic, Lunit, Aidoc, Contextflow and Butterfly Network, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-based Medical Imaging Tool market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-based Medical Imaging Tool and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-based Medical Imaging Tool revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-based Medical Imaging Tool market.

AI-based Medical Imaging Tool Segment by Company

ScreenPoint Medical

Volpara Solutions

CureMetrix

Densitas

Enlitic

Lunit

Aidoc

Contextflow

Butterfly Network

QView Medical

Brainomix

4Quant

Quibim

Qure

Methinks

Blackford Analysis

Behold

Nanox

Siemens Healthineers (AI-Rad Companion)

Rad AI

Harrison.ai

Paxera UltimaAi

Viz.ai

Gleamer

Arterys

EnvoyAI

ContextVision

General Electric

Fujifilm

iCAD

Nuance Communications

Beijing Infervision Technology

Beijing Shenrui Bolian

RapidAI

AI-based Medical Imaging Tool Segment by Type

Breast Imaging

Cardiovascular Imaging

Lung Imaging

Neurological Imaging

Other

AI-based Medical Imaging Tool Segment by Application

Hospital

Clinic

Research Institutions

AI-based Medical Imaging Tool Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-based Medical Imaging Tool status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-based Medical Imaging Tool key companies, revenue, market share, and recent developments.

3. To split the AI-based Medical Imaging Tool breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-based Medical Imaging Tool market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-based Medical Imaging Tool significant trends, drivers, influence factors in global and regions.

6. To analyze AI-based Medical Imaging Tool competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Medical Imaging Tool market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Medical Imaging Tool and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Medical Imaging Tool.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-based Medical Imaging Tool industry.

Chapter 3: Detailed analysis of AI-based Medical Imaging Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-based Medical Imaging Tool in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-based Medical Imaging Tool in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-based Medical Imaging Tool Industry Trends Table 2. AI-based Medical Imaging Tool Industry Drivers Table 3. AI-based Medical Imaging Tool Industry Opportunities and Challenges Table 4. AI-based Medical Imaging Tool Industry Restraints Table 5. Global AI-based Medical Imaging Tool Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-based Medical Imaging Tool Revenue Share by Company (2021-2026) Table 7. Global AI-based Medical Imaging Tool Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-based Medical Imaging Tool Key Company Manufacturing Base & Headquarters Table 9. Global AI-based Medical Imaging Tool Company, Product Type & Application Table 10. Global AI-based Medical Imaging Tool Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-based Medical Imaging Tool by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Breast Imaging Table 15. Significant Companies of Cardiovascular Imaging Table 16. Significant Companies of Lung Imaging Table 17. Significant Companies of Neurological Imaging Table 18. Significant Companies of Other Table 19. Global AI-based Medical Imaging Tool Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global AI-based Medical Imaging Tool Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global AI-based Medical Imaging Tool Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global AI-based Medical Imaging Tool Sales Value Share by Type (2021-2026) Table 23. Global AI-based Medical Imaging Tool Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Research Institutions Table 27. Global AI-based Medical Imaging Tool Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI-based Medical Imaging Tool Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global AI-based Medical Imaging Tool Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global AI-based Medical Imaging Tool Sales Value Share by Application (2021-2026) Table 31. Global AI-based Medical Imaging Tool Sales Value Share by Application (2027-2032) Table 32. Global AI-based Medical Imaging Tool Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI-based Medical Imaging Tool Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global AI-based Medical Imaging Tool Sales Value Share by Region (2021-2026) Table 35. Global AI-based Medical Imaging Tool Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global AI-based Medical Imaging Tool Sales Value Share by Region (2027-2032) Table 37. Global AI-based Medical Imaging Tool Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI-based Medical Imaging Tool Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global AI-based Medical Imaging Tool Sales Value Market Share by Country (2021-2026) Table 40. Global AI-based Medical Imaging Tool Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global AI-based Medical Imaging Tool Sales Value Market Share by Country (2027-2032) Table 42. ScreenPoint Medical Company Information Table 43. ScreenPoint Medical Business Overview Table 44. ScreenPoint Medical AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. ScreenPoint Medical AI-based Medical Imaging Tool Product Portfolio Table 46. ScreenPoint Medical Recent Development Table 47. Volpara Solutions Company Information Table 48. Volpara Solutions Business Overview Table 49. Volpara Solutions AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Volpara Solutions AI-based Medical Imaging Tool Product Portfolio Table 51. Volpara Solutions Recent Development Table 52. CureMetrix Company Information Table 53. CureMetrix Business Overview Table 54. CureMetrix AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. CureMetrix AI-based Medical Imaging Tool Product Portfolio Table 56. CureMetrix Recent Development Table 57. Densitas Company Information Table 58. Densitas Business Overview Table 59. Densitas AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Densitas AI-based Medical Imaging Tool Product Portfolio Table 61. Densitas Recent Development Table 62. Enlitic Company Information Table 63. Enlitic Business Overview Table 64. Enlitic AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Enlitic AI-based Medical Imaging Tool Product Portfolio Table 66. Enlitic Recent Development Table 67. Lunit Company Information Table 68. Lunit Business Overview Table 69. Lunit AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lunit AI-based Medical Imaging Tool Product Portfolio Table 71. Lunit Recent Development Table 72. Aidoc Company Information Table 73. Aidoc Business Overview Table 74. Aidoc AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Aidoc AI-based Medical Imaging Tool Product Portfolio Table 76. Aidoc Recent Development Table 77. Contextflow Company Information Table 78. Contextflow Business Overview Table 79. Contextflow AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Contextflow AI-based Medical Imaging Tool Product Portfolio Table 81. Contextflow Recent Development Table 82. Butterfly Network Company Information Table 83. Butterfly Network Business Overview Table 84. Butterfly Network AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Butterfly Network AI-based Medical Imaging Tool Product Portfolio Table 86. Butterfly Network Recent Development Table 87. QView Medical Company Information Table 88. QView Medical Business Overview Table 89. QView Medical AI-based Medical Imaging Tool Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. QView Medical AI-based Medical Imaging Tool Product Portfolio Table 91. QView Medical Recent Development Table 92. Brainomix Company Information Table 93. Brainomix Business Overview Table 94. Brainomix AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Brainomix AI-based Medical Imaging Tool Product Portfolio Table 96. Brainomix Recent Development Table 97. 4Quant Company Information Table 98. 4Quant Business Overview Table 99. 4Quant AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. 4Quant AI-based Medical Imaging Tool Product Portfolio Table 101. 4Quant Recent Development Table 102. Quibim Company Information Table 103. Quibim Business Overview Table 104. Quibim AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Quibim AI-based Medical Imaging Tool Product Portfolio Table 106. Quibim Recent Development Table 107. Qure Company Information Table 108. Qure Business Overview Table 109. Qure AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Qure AI-based Medical Imaging Tool Product Portfolio Table 111. Qure Recent Development Table 112. Methinks Company Information Table 113. Methinks Business Overview Table 114. Methinks AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Methinks AI-based Medical Imaging Tool Product Portfolio Table 116. Methinks Recent Development Table 117. Blackford Analysis Company Information Table 118. Blackford Analysis Business Overview Table 119. Blackford Analysis AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Blackford Analysis AI-based Medical Imaging Tool Product Portfolio Table 121. Blackford Analysis Recent Development Table 122. Behold Company Information Table 123. Behold Business Overview Table 124. Behold AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Behold AI-based Medical Imaging Tool Product Portfolio Table 126. Behold Recent Development Table 127. Nanox Company Information Table 128. Nanox Business Overview Table 129. Nanox AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Nanox AI-based Medical Imaging Tool Product Portfolio Table 131. Nanox Recent Development Table 132. Siemens Healthineers (AI-Rad Companion) Company Information Table 133. Siemens Healthineers (AI-Rad Companion) Business Overview Table 134. Siemens Healthineers (AI-Rad Companion) AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Siemens Healthineers (AI-Rad Companion) AI-based Medical Imaging Tool Product Portfolio Table 136. Siemens Healthineers (AI-Rad Companion) Recent Development Table 137. Rad AI Company Information Table 138. Rad AI Business Overview Table 139. Rad AI AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Rad AI AI-based Medical Imaging Tool Product Portfolio Table 141. Rad AI Recent Development Table 142. Harrison.ai Company Information Table 143. Harrison.ai Business Overview Table 144. Harrison.ai AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Harrison.ai AI-based Medical Imaging Tool Product Portfolio Table 146. Harrison.ai Recent Development Table 147. Paxera UltimaAi Company Information Table 148. Paxera UltimaAi Business Overview Table 149. Paxera UltimaAi AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Paxera UltimaAi AI-based Medical Imaging Tool Product Portfolio Table 151. Paxera UltimaAi Recent Development Table 152. Viz.ai Company Information Table 153. Viz.ai Business Overview Table 154. Viz.ai AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Viz.ai AI-based Medical Imaging Tool Product Portfolio Table 156. Viz.ai Recent Development Table 157. Gleamer Company Information Table 158. Gleamer Business Overview Table 159. Gleamer AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Gleamer AI-based Medical Imaging Tool Product Portfolio Table 161. Gleamer Recent Development Table 162. Arterys Company Information Table 163. Arterys Business Overview Table 164. Arterys AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Arterys AI-based Medical Imaging Tool Product Portfolio Table 166. Arterys Recent Development Table 167. EnvoyAI Company Information Table 168. EnvoyAI Business Overview Table 169. EnvoyAI AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. EnvoyAI AI-based Medical Imaging Tool Product Portfolio Table 171. EnvoyAI Recent Development Table 172. ContextVision Company Information Table 173. ContextVision Business Overview Table 174. ContextVision AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. ContextVision AI-based Medical Imaging Tool Product Portfolio Table 176. ContextVision Recent Development Table 177. General Electric Company Information Table 178. General Electric Business Overview Table 179. General Electric AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. General Electric AI-based Medical Imaging Tool Product Portfolio Table 181. General Electric Recent Development Table 182. Fujifilm Company Information Table 183. Fujifilm Business Overview Table 184. Fujifilm AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Fujifilm AI-based Medical Imaging Tool Product Portfolio Table 186. Fujifilm Recent Development Table 187. iCAD Company Information Table 188. iCAD Business Overview Table 189. iCAD AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. iCAD AI-based Medical Imaging Tool Product Portfolio Table 191. iCAD Recent Development Table 192. Nuance Communications Company Information Table 193. Nuance Communications Business Overview Table 194. Nuance Communications AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Nuance Communications AI-based Medical Imaging Tool Product Portfolio Table 196. Nuance Communications Recent Development Table 197. Beijing Infervision Technology Company Information Table 198. Beijing Infervision Technology Business Overview Table 199. Beijing Infervision Technology AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Beijing Infervision Technology AI-based Medical Imaging Tool Product Portfolio Table 201. Beijing Infervision Technology Recent Development Table 202. Beijing Shenrui Bolian Company Information Table 203. Beijing Shenrui Bolian Business Overview Table 204. Beijing Shenrui Bolian AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Beijing Shenrui Bolian AI-based Medical Imaging Tool Product Portfolio Table 206. Beijing Shenrui Bolian Recent Development Table 207. RapidAI Company Information Table 208. RapidAI Business Overview Table 209. RapidAI AI-based Medical Imaging Tool Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. RapidAI AI-based Medical Imaging Tool Product Portfolio Table 211. RapidAI Recent Development Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. AI-based Medical Imaging Tool Product Image Figure 2. Global AI-based Medical Imaging Tool Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-based Medical Imaging Tool Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-based Medical Imaging Tool Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Breast Imaging Image Figure 8. Cardiovascular Imaging Image Figure 9. Lung Imaging Image Figure 10. Neurological Imaging Image Figure 11. Other Image Figure 12. Global AI-based Medical Imaging Tool Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global AI-based Medical Imaging Tool Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global AI-based Medical Imaging Tool Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Research Institutions Image Figure 18. Global AI-based Medical Imaging Tool Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI-based Medical Imaging Tool Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global AI-based Medical Imaging Tool Sales Value Share by Application (2021-2032) Figure 21. Global AI-based Medical Imaging Tool Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global AI-based Medical Imaging Tool Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America AI-based Medical Imaging Tool Sales Value (2021-2032) & (US$ Million) Figure 24. North America AI-based Medical Imaging Tool Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe AI-based Medical Imaging Tool Sales Value (2021-2032) & (US$ Million) Figure 26. Europe AI-based Medical Imaging Tool Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific AI-based Medical Imaging Tool Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific AI-based Medical Imaging Tool Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America AI-based Medical Imaging Tool Sales Value (2021-2032) & (US$ Million) Figure 30. South America AI-based Medical Imaging Tool Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa AI-based Medical Imaging Tool Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa AI-based Medical Imaging Tool Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Breast Imaging
  • Cardiovascular Imaging
  • Lung Imaging
  • Neurological Imaging
  • Other
Applications
  • Hospital
  • Clinic
  • Research Institutions
Companies covered
  • ScreenPoint Medical
  • Volpara Solutions
  • CureMetrix
  • Densitas
  • Enlitic
  • Lunit
  • Aidoc
  • Contextflow
  • Butterfly Network
  • QView Medical
  • Brainomix
  • 4Quant
  • Quibim
  • Qure
  • Methinks
  • Blackford Analysis
  • Behold
  • Nanox
  • Siemens Healthineers (AI-Rad Companion)
  • Rad AI
  • Harrison.ai
  • Paxera UltimaAi
  • Viz.ai
  • Gleamer
  • Arterys
  • EnvoyAI
  • ContextVision
  • General Electric
  • Fujifilm
  • iCAD
  • Nuance Communications
  • Beijing Infervision Technology
  • Beijing Shenrui Bolian
  • RapidAI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-based Medical Imaging Tool Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-based Medical Imaging Tool Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-based Medical Imaging Tool Market Dynamics
  1. 2.1 AI-based Medical Imaging Tool Industry Trends
  2. 2.2 AI-based Medical Imaging Tool Industry Drivers
  3. 2.3 AI-based Medical Imaging Tool Industry Opportunities and Challenges
  4. 2.4 AI-based Medical Imaging Tool Industry Restraints
3 AI-based Medical Imaging Tool Market by Company
  1. 3.1 Global AI-based Medical Imaging Tool Company Revenue Ranking in 2025
  2. 3.2 Global AI-based Medical Imaging Tool Revenue by Company (2021-2026)
  3. 3.3 Global AI-based Medical Imaging Tool Company Ranking (2024-2026)
  4. 3.4 Global AI-based Medical Imaging Tool Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-based Medical Imaging Tool Company Product Type and Application
  6. 3.6 Global AI-based Medical Imaging Tool Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-based Medical Imaging Tool Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-based Medical Imaging Tool Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-based Medical Imaging Tool Market by Type
  1. 4.1 AI-based Medical Imaging Tool Type Introduction
  2. 4.1.1 Breast Imaging
  3. 4.1.2 Cardiovascular Imaging
  4. 4.1.3 Lung Imaging
  5. 4.1.4 Neurological Imaging
  6. 4.1.5 Other
  7. 4.2 Global AI-based Medical Imaging Tool Sales Value by Type
  8. 4.2.1 Global AI-based Medical Imaging Tool Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global AI-based Medical Imaging Tool Sales Value by Type (2021-2032)
  10. 4.2.3 Global AI-based Medical Imaging Tool Sales Value Share by Type (2021-2032)
5 AI-based Medical Imaging Tool Market by Application
  1. 5.1 AI-based Medical Imaging Tool Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Research Institutions
  5. 5.2 Global AI-based Medical Imaging Tool Sales Value by Application
  6. 5.2.1 Global AI-based Medical Imaging Tool Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI-based Medical Imaging Tool Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI-based Medical Imaging Tool Sales Value Share by Application (2021-2032)
6 AI-based Medical Imaging Tool Regional Value Analysis
  1. 6.1 Global AI-based Medical Imaging Tool Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-based Medical Imaging Tool Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-based Medical Imaging Tool Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-based Medical Imaging Tool Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-based Medical Imaging Tool Sales Value (2021-2032)
  7. 6.3.2 North America AI-based Medical Imaging Tool Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-based Medical Imaging Tool Sales Value (2021-2032)
  10. 6.4.2 Europe AI-based Medical Imaging Tool Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-based Medical Imaging Tool Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-based Medical Imaging Tool Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-based Medical Imaging Tool Sales Value (2021-2032)
  16. 6.6.2 South America AI-based Medical Imaging Tool Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-based Medical Imaging Tool Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-based Medical Imaging Tool Sales Value Share by Country, 2025 VS 2032
7 AI-based Medical Imaging Tool Country-level Value Analysis
  1. 7.1 Global AI-based Medical Imaging Tool Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-based Medical Imaging Tool Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-based Medical Imaging Tool Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-based Medical Imaging Tool Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-based Medical Imaging Tool Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-based Medical Imaging Tool Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-based Medical Imaging Tool Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ScreenPoint Medical
  2. 8.1.1 ScreenPoint Medical Company Information
  3. 8.1.2 ScreenPoint Medical Business Overview
  4. 8.1.3 ScreenPoint Medical AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ScreenPoint Medical AI-based Medical Imaging Tool Product Portfolio
  6. 8.1.5 ScreenPoint Medical Recent Developments
  7. 8.2 Volpara Solutions
  8. 8.2.1 Volpara Solutions Company Information
  9. 8.2.2 Volpara Solutions Business Overview
  10. 8.2.3 Volpara Solutions AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Volpara Solutions AI-based Medical Imaging Tool Product Portfolio
  12. 8.2.5 Volpara Solutions Recent Developments
  13. 8.3 CureMetrix
  14. 8.3.1 CureMetrix Company Information
  15. 8.3.2 CureMetrix Business Overview
  16. 8.3.3 CureMetrix AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CureMetrix AI-based Medical Imaging Tool Product Portfolio
  18. 8.3.5 CureMetrix Recent Developments
  19. 8.4 Densitas
  20. 8.4.1 Densitas Company Information
  21. 8.4.2 Densitas Business Overview
  22. 8.4.3 Densitas AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Densitas AI-based Medical Imaging Tool Product Portfolio
  24. 8.4.5 Densitas Recent Developments
  25. 8.5 Enlitic
  26. 8.5.1 Enlitic Company Information
  27. 8.5.2 Enlitic Business Overview
  28. 8.5.3 Enlitic AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Enlitic AI-based Medical Imaging Tool Product Portfolio
  30. 8.5.5 Enlitic Recent Developments
  31. 8.6 Lunit
  32. 8.6.1 Lunit Company Information
  33. 8.6.2 Lunit Business Overview
  34. 8.6.3 Lunit AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lunit AI-based Medical Imaging Tool Product Portfolio
  36. 8.6.5 Lunit Recent Developments
  37. 8.7 Aidoc
  38. 8.7.1 Aidoc Company Information
  39. 8.7.2 Aidoc Business Overview
  40. 8.7.3 Aidoc AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aidoc AI-based Medical Imaging Tool Product Portfolio
  42. 8.7.5 Aidoc Recent Developments
  43. 8.8 Contextflow
  44. 8.8.1 Contextflow Company Information
  45. 8.8.2 Contextflow Business Overview
  46. 8.8.3 Contextflow AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Contextflow AI-based Medical Imaging Tool Product Portfolio
  48. 8.8.5 Contextflow Recent Developments
  49. 8.9 Butterfly Network
  50. 8.9.1 Butterfly Network Company Information
  51. 8.9.2 Butterfly Network Business Overview
  52. 8.9.3 Butterfly Network AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Butterfly Network AI-based Medical Imaging Tool Product Portfolio
  54. 8.9.5 Butterfly Network Recent Developments
  55. 8.10 QView Medical
  56. 8.10.1 QView Medical Company Information
  57. 8.10.2 QView Medical Business Overview
  58. 8.10.3 QView Medical AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QView Medical AI-based Medical Imaging Tool Product Portfolio
  60. 8.10.5 QView Medical Recent Developments
  61. 8.11 Brainomix
  62. 8.11.1 Brainomix Company Information
  63. 8.11.2 Brainomix Business Overview
  64. 8.11.3 Brainomix AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Brainomix AI-based Medical Imaging Tool Product Portfolio
  66. 8.11.5 Brainomix Recent Developments
  67. 8.12 4Quant
  68. 8.12.1 4Quant Company Information
  69. 8.12.2 4Quant Business Overview
  70. 8.12.3 4Quant AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  71. 8.12.4 4Quant AI-based Medical Imaging Tool Product Portfolio
  72. 8.12.5 4Quant Recent Developments
  73. 8.13 Quibim
  74. 8.13.1 Quibim Company Information
  75. 8.13.2 Quibim Business Overview
  76. 8.13.3 Quibim AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Quibim AI-based Medical Imaging Tool Product Portfolio
  78. 8.13.5 Quibim Recent Developments
  79. 8.14 Qure
  80. 8.14.1 Qure Company Information
  81. 8.14.2 Qure Business Overview
  82. 8.14.3 Qure AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Qure AI-based Medical Imaging Tool Product Portfolio
  84. 8.14.5 Qure Recent Developments
  85. 8.15 Methinks
  86. 8.15.1 Methinks Company Information
  87. 8.15.2 Methinks Business Overview
  88. 8.15.3 Methinks AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Methinks AI-based Medical Imaging Tool Product Portfolio
  90. 8.15.5 Methinks Recent Developments
  91. 8.16 Blackford Analysis
  92. 8.16.1 Blackford Analysis Company Information
  93. 8.16.2 Blackford Analysis Business Overview
  94. 8.16.3 Blackford Analysis AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Blackford Analysis AI-based Medical Imaging Tool Product Portfolio
  96. 8.16.5 Blackford Analysis Recent Developments
  97. 8.17 Behold
  98. 8.17.1 Behold Company Information
  99. 8.17.2 Behold Business Overview
  100. 8.17.3 Behold AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Behold AI-based Medical Imaging Tool Product Portfolio
  102. 8.17.5 Behold Recent Developments
  103. 8.18 Nanox
  104. 8.18.1 Nanox Company Information
  105. 8.18.2 Nanox Business Overview
  106. 8.18.3 Nanox AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Nanox AI-based Medical Imaging Tool Product Portfolio
  108. 8.18.5 Nanox Recent Developments
  109. 8.19 Siemens Healthineers (AI-Rad Companion)
  110. 8.19.1 Siemens Healthineers (AI-Rad Companion) Company Information
  111. 8.19.2 Siemens Healthineers (AI-Rad Companion) Business Overview
  112. 8.19.3 Siemens Healthineers (AI-Rad Companion) AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Siemens Healthineers (AI-Rad Companion) AI-based Medical Imaging Tool Product Portfolio
  114. 8.19.5 Siemens Healthineers (AI-Rad Companion) Recent Developments
  115. 8.20 Rad AI
  116. 8.20.1 Rad AI Company Information
  117. 8.20.2 Rad AI Business Overview
  118. 8.20.3 Rad AI AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Rad AI AI-based Medical Imaging Tool Product Portfolio
  120. 8.20.5 Rad AI Recent Developments
  121. 8.21 Harrison.ai
  122. 8.21.1 Harrison.ai Company Information
  123. 8.21.2 Harrison.ai Business Overview
  124. 8.21.3 Harrison.ai AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Harrison.ai AI-based Medical Imaging Tool Product Portfolio
  126. 8.21.5 Harrison.ai Recent Developments
  127. 8.22 Paxera UltimaAi
  128. 8.22.1 Paxera UltimaAi Company Information
  129. 8.22.2 Paxera UltimaAi Business Overview
  130. 8.22.3 Paxera UltimaAi AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Paxera UltimaAi AI-based Medical Imaging Tool Product Portfolio
  132. 8.22.5 Paxera UltimaAi Recent Developments
  133. 8.23 Viz.ai
  134. 8.23.1 Viz.ai Company Information
  135. 8.23.2 Viz.ai Business Overview
  136. 8.23.3 Viz.ai AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Viz.ai AI-based Medical Imaging Tool Product Portfolio
  138. 8.23.5 Viz.ai Recent Developments
  139. 8.24 Gleamer
  140. 8.24.1 Gleamer Company Information
  141. 8.24.2 Gleamer Business Overview
  142. 8.24.3 Gleamer AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Gleamer AI-based Medical Imaging Tool Product Portfolio
  144. 8.24.5 Gleamer Recent Developments
  145. 8.25 Arterys
  146. 8.25.1 Arterys Company Information
  147. 8.25.2 Arterys Business Overview
  148. 8.25.3 Arterys AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Arterys AI-based Medical Imaging Tool Product Portfolio
  150. 8.25.5 Arterys Recent Developments
  151. 8.26 EnvoyAI
  152. 8.26.1 EnvoyAI Company Information
  153. 8.26.2 EnvoyAI Business Overview
  154. 8.26.3 EnvoyAI AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  155. 8.26.4 EnvoyAI AI-based Medical Imaging Tool Product Portfolio
  156. 8.26.5 EnvoyAI Recent Developments
  157. 8.27 ContextVision
  158. 8.27.1 ContextVision Company Information
  159. 8.27.2 ContextVision Business Overview
  160. 8.27.3 ContextVision AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  161. 8.27.4 ContextVision AI-based Medical Imaging Tool Product Portfolio
  162. 8.27.5 ContextVision Recent Developments
  163. 8.28 General Electric
  164. 8.28.1 General Electric Company Information
  165. 8.28.2 General Electric Business Overview
  166. 8.28.3 General Electric AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  167. 8.28.4 General Electric AI-based Medical Imaging Tool Product Portfolio
  168. 8.28.5 General Electric Recent Developments
  169. 8.29 Fujifilm
  170. 8.29.1 Fujifilm Company Information
  171. 8.29.2 Fujifilm Business Overview
  172. 8.29.3 Fujifilm AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Fujifilm AI-based Medical Imaging Tool Product Portfolio
  174. 8.29.5 Fujifilm Recent Developments
  175. 8.30 iCAD
  176. 8.30.1 iCAD Company Information
  177. 8.30.2 iCAD Business Overview
  178. 8.30.3 iCAD AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  179. 8.30.4 iCAD AI-based Medical Imaging Tool Product Portfolio
  180. 8.30.5 iCAD Recent Developments
  181. 8.31 Nuance Communications
  182. 8.31.1 Nuance Communications Company Information
  183. 8.31.2 Nuance Communications Business Overview
  184. 8.31.3 Nuance Communications AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Nuance Communications AI-based Medical Imaging Tool Product Portfolio
  186. 8.31.5 Nuance Communications Recent Developments
  187. 8.32 Beijing Infervision Technology
  188. 8.32.1 Beijing Infervision Technology Company Information
  189. 8.32.2 Beijing Infervision Technology Business Overview
  190. 8.32.3 Beijing Infervision Technology AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Beijing Infervision Technology AI-based Medical Imaging Tool Product Portfolio
  192. 8.32.5 Beijing Infervision Technology Recent Developments
  193. 8.33 Beijing Shenrui Bolian
  194. 8.33.1 Beijing Shenrui Bolian Company Information
  195. 8.33.2 Beijing Shenrui Bolian Business Overview
  196. 8.33.3 Beijing Shenrui Bolian AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Beijing Shenrui Bolian AI-based Medical Imaging Tool Product Portfolio
  198. 8.33.5 Beijing Shenrui Bolian Recent Developments
  199. 8.34 RapidAI
  200. 8.34.1 RapidAI Company Information
  201. 8.34.2 RapidAI Business Overview
  202. 8.34.3 RapidAI AI-based Medical Imaging Tool Revenue and Gross Margin (2021-2026)
  203. 8.34.4 RapidAI AI-based Medical Imaging Tool Product Portfolio
  204. 8.34.5 RapidAI Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst